Risk of Dyslipidemia Associated with VEGF/VEGFR Inhibitors: A Meta-Analysis

OBJECTIVE: This meta-analysis was performed to investigate hyperlipidemia in patients with carcinoma treated with vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor (VEGFR) inhibitors. METHODS: We searched for eligible phase II and III studies using PubMed and Emba...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Huihui, Liu, Chang, Li, Peijuan, Mai, Zhangfeng, Tan, Xiaoming, Chen, Sijing, Zhou, Ziling, Tang, Zhiben, Miao, Jingwei, Liu, Lizhong, Fang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205761/
https://www.ncbi.nlm.nih.gov/pubmed/32375082
http://dx.doi.org/10.1016/j.tranon.2020.100779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205761/
https://www.ncbi.nlm.nih.gov/pubmed/32375082
http://dx.doi.org/10.1016/j.tranon.2020.100779

Ejemplares similares